ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,090.27
0.25%
US Tech 100
21,038.00
0.79%
Dow Jones
44,642.52
-0.28%
Brent Oil
71.20
0.12%
Bitcoin
99,739.09
-1.48%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Argen X SE (ARGX) Quote

Argen X SE

Argen X SE (ARGX)

argenx SE
590.80
-1.20
(-0.20%)
Closed December 08 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
590.80
Bid
586.00
Ask
594.00
Volume
37,148
589.80 Day's Range 594.80
271.00 52 Week Range 595.80
Market Cap
34.972B
Previous Close
592.00
Open
590.00
Last Trade
140
@
590.8
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
61,328
Shares Outstanding
59,194,000
Dividend Yield
-
PE Ratio
-118.53
Earnings Per Share (EPS)
-4.98
Revenue
1.27B
Net Profit
-295.05M

About Argen X SE

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
www.argenx.com
Headquarters
Amsterdam, North Holland, Nld
Founded
-
Argen X SE is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker ARGX. The last closing price for Argen X was 592.00 €. Over the last year, Argen X shares have traded in a share price range of 271.00 € to 595.80 €.

Argen X currently has 59,194,000 shares outstanding. The market capitalization of Argen X is 35.04 € billion. Argen X has a price to earnings ratio (PE ratio) of -118.53.

Ask ADVFN Intelligence (AI)

ARGX Latest News

More News

argenx to Present at Upcoming Investor Conferences

November 26, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

November 26 2024
GlobeNewswire Inc.

argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies

Phase 2 data establish proof-of-concept of efgartigimod SC in myositis Enrollment to continue in Phase 3 across all three subtypes (IMNM, ASyS, DM) under evaluation in ALKIVIAPotential for...

November 20 2024
GlobeNewswire Inc.

argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China

First and only NMPA-approved treatment for patients with CIDP in China  Second VYVGART Hytrulo indication approved in China  November 11, 2024 – 7:30am ET  Amsterdam, the Netherlands— argenx...

November 11 2024
GlobeNewswire Inc.

argenx to Participate at Upcoming Investor Conferences

November 5, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

November 05 2024
GlobeNewswire Inc.

argenx Reports Third Quarter 2024 Financial Results and Provides Business Update

$573 million in third quarter global net product sales CIDP global expansion on track, with decisions on approval under review in Japan, Europe, China, and Canada Management to host conference...

October 31 2024
GlobeNewswire Inc.

argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024

October 24, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

October 24 2024
GlobeNewswire Inc.

argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions

Long-term and real-world data of VYVGART® (efgartigimod alfa-fcab) and VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrate speed of onset, depth of response, and durability...

October 15 2024
GlobeNewswire Inc.

argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy

ADHERE was largest and most innovative clinical trial of CIDP patients to date VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrated reduction in disease progression, reduced...

September 19 2024
GlobeNewswire Inc.

argenx to Present at Upcoming Investor Conferences

August 28, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune...

August 28 2024
GlobeNewswire Inc.

argenx Reports Half Year 2024 Financial Results and Provides Second Quarter Business Update

$478 million in second quarter global net product sales First CIDP patients treated with VYVGART® Hytrulo following June 21st FDA approval On track to begin four additional registrational...

July 25 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.60.101660454083590.2595.8577.845516589.09963353DE
441.67.57465404224549.2595.8527.867447570.24846035DE
12104.821.5637860082486595.8456.361328526.84022303DE
26237.867.3654390935353595.8342.862254475.57961291DE
52162.337.8763127188428.5595.827162626415.37036841DE
156335.1131.052014079255.7595.8224.165532372.51908932DE
260454.9334.731420162135.9595.893.0574906294.67282487DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EBUSEbusco Holding NV
1.755 €
(25.25%)
5.64M
SEQUASequana medical NV
0.85 €
(24.63%)
239.85k
ALENOEnogia SA
1.785 €
(14.79%)
84.12k
ALNOVNovacyt
0.639 €
(14.11%)
922.72k
UBIUBISoft Entertainment
13.32 €
(13.07%)
1.71M
ATOAtos SE
0.0026 €
(-98.54%)
1.31B
ALSPWSpineway
0.0798 €
(-21.15%)
3.56M
ALCBICrypto Blockchain Industries
0.1665 €
(-19.95%)
712.38k
ALDVIAdvicenne
1.742 €
(-19.16%)
122.88k
ALAGOEPango SA
0.1178 €
(-16.45%)
7.39M
ATOAtos SE
0.0026 €
(-98.54%)
1.31B
BCPBanco Comercial Portugues SA
0.4397 €
(-2.96%)
73.03M
ALTDTonner Drones
0.011 €
(3.77%)
43.43M
ALCYBCybergun
0.0001 €
(0.00%)
23.43M
INGAING Groep NV
15.044 €
(-0.88%)
8.62M

Discussion

View Full Feed
dbob dbob 1 minute ago
Mascale why do you even go toe to toe with those three clowns that want to bash. Your wasting your time. When this goes viral and nuts on all the boards those 3 imbeciles will still be imbeciles
HIRU
nowwhat2 nowwhat2 1 minute ago
Yeah.....Cryptos are a real good "store of value".

https://investorshub.advfn.com/uimage/uploads/2024/12/8/usngmbtc_121212_8_15d_430pm_100000_jack_ass.jpg


https://www.youtube.com/watch?v=MnRLk5jQC2M


3 DAYS EARLIER

https://i
gitreal gitreal 2 minutes ago
No, he can't. That's illegal.
AABB
I-Glow I-Glow 2 minutes ago
Spooz is down 68% since the high of $0.013 in May.

You do know that Spooz was at $0.013 for a cup of coffee and closed on May 3rd at $0.0102 from being at $0.013 earlier that day - so you aren't being truthful if you said you sold at $0.013 - as it closed down 22% from the high that d
SPZI
MiamiGent MiamiGent 2 minutes ago
I wonder if Pres-elect Trump should skip the outdoor inauguration and just have it in the rotundra. Skip the balls.
I really worry that big bad players will make another attempt(s)
He does not need to expose himself. He's won. There's nothing to be gained. Go into severe protection mo
bas2020 bas2020 3 minutes ago
Don't play stupid, stupid. 👿☠️
NWBO
ironhammer ironhammer 3 minutes ago
just wondering if there is a good mining fourm on I hub there are one or two but no one posted on them let me know . NBRI is going to be a great investment .good trades to all
NBRI
Investor082 Investor082 3 minutes ago
Lawsuit is indeed a winning strategy for bag holders or pretend longs. LP would love to recruit more of such bag holders for the next decade full of dilution!
NWBO
mascale mascale 3 minutes ago
OTCID recognizes change, widely unknown to IHUB, e. g. waterchaser poster, Jack_Herer poster, mineanddine poster, and contrary posters: Clearly not literate, not too up on things. July 2025 is in the calendar even, among the literate--some unware!
HIRU
theorysuit theorysuit 4 minutes ago
What does their holdings have to do with nwbo? Nothing. This company can't even submit applications for themselves. One application in over 4.5 years since data lock and in a non consequential market. That sounds like something BP should be afraid of??? Keep spouting off the blame on extern
NWBO
weedtrader420 weedtrader420 5 minutes ago
You think you’re trading OTC that’s why you lose money
XRPUSD
intuitive3 intuitive3 5 minutes ago
Why keep it a secret?
COOP
Genz2 Genz2 5 minutes ago
https://cybersecuritynews.com/deliotte-data-breach-denied/amp/

Methinks, many years ago PwC used Wave to turn on its TPMs for their 2FA, and as I recall they didn’t have any breaches!! Wave got better with being able to roll out its 2FA at scale a lot faster with its Wave VSC!! Sinc
bas2020 bas2020 5 minutes ago
No... it's KG who has screwed over NWBO for a decade. FACT! That's why they are being sued.
Get it? 👿☠️
NWBO
jay_tee jay_tee 6 minutes ago
I wonder what Jolly is up to. He invested in this st around .004. Seamus doesn't even call his boy anymore to promote. What is up with that??
RNVA
Hardazoak Hardazoak 6 minutes ago
Why would aabb know what clive does? Clive is not the company. He can split his converted shares into blocks under 5% and put each conversion under a dozen different names. Stop with the lies doe.
AABB
weedtrader420 weedtrader420 7 minutes ago
Who the hell takes 60 minutes serious, who even watches it
XRPUSD
Investor082 Investor082 7 minutes ago
LP is the CEO of NWBO. I know bag holders don't get that simple concept and are looking for excuses to justify the significant losses (up to 90%) over the years.

Come up with better excuses after LP screws investors again post UK approval with endless dilution!
NWBO
dinogreeves dinogreeves 7 minutes ago
Overnight volume doesn't mean anything, especially with Robinhookers and sometimes not even with Webull, countdown to 7 AM has started, that is when things will get interesting and after opening bell.

https://robinhood.com/us/en/stocks/SMCI/
SMCI
SilkRoad SilkRoad 7 minutes ago
When I see GREEN mulberry fields and SILKWORMS munching I just think all that doesn’t matter. We’re in 2024 and about to hit “multi-ton” production in 2025. So all that backward looking don’t mean nothin’.

https://www.youtube.com/watch?v=lip5ubLT1X0
KBLB
Remember Tomorrow Remember Tomorrow 7 minutes ago
That 60 minutes interview was awful. I should have known they'd do what they always do and shape a narrative to what they want it to be which in this case was to present crypto in a very negative way.

Remember Tomorrow
XRPUSD
delerious1 delerious1 9 minutes ago
Markets open in 13.5 hours....could be good
NBRI Rocks!!!!
NBRI
PatentGuy1 PatentGuy1 10 minutes ago
At least the Evie ring isn’t a knife nor just a proof of concept item.
LQMT

Your Recent History

EU
ARGX
Argen X
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved